The ratio of eicosapentaenoic acid (EPA) to arachidonic acid may be a residual risk marker in stable coronary artery disease patients receiving treatment with statin following EPA therapy
Event:
ESC Congress 2016
Topic:
Adjunctive medical therapy
Session:
Adjunctive medical therapy in coronary artery disease